ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Therapy in Oncology Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-20J14230
Home | Market Reports | Health| Health Conditions| Cancer
Global Gene Therapy in Oncology Market Research Report 2023
BUY CHAPTERS

Global Gene Therapy in Oncology Market Research Report 2025

Code: QYRE-Auto-20J14230
Report
September 2025
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb
Cold Genesys
Advantagene Inc
Amgen Inc
Astrazeneca plc
Bio-Path Holdings
CRISPR Therapeutics
Editas Medicine
Geron Corp
Idera Pharmaceuticals
Intellia Therapeutics
Johnson & Johnson
Marsala Biotech
Merck
Mologen AG
Oncolytics Biotech
Oncosec
Oncotelic
Shenzhen SiBiono GeneTech
Tocagen
Uniqure
ZIOPHARM Oncology
Sillajen BiOthersapeutics
Johnson & Johnson

Gene Therapy in Oncology Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gene Therapy in Oncology Market

Gene Therapy in Oncology Market

The global market for Gene Therapy in Oncology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient. 
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy in Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy in Oncology.
The Gene Therapy in Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapy in Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy in Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gene Therapy in Oncology Market Report

Report Metric Details
Report Name Gene Therapy in Oncology Market
CAGR 5%
Segment by Type
  • Ex Vivo
  • In Vivo
Segment by Application
  • Hospitals
  • Diagnostics Centers
  • Research Institutes
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bristol-Myers Squibb, Cold Genesys, Advantagene, Amgen, AstraZeneca, Bio-Path Holdings, CRISPR Therapeutics, Editas Medicine, Geron Corp, Idera Pharmaceuticals, Intellia Therapeutics, Johnson & Johnson, Marsala Biotech, Merck, Mologen AG, Oncolytics Biotech, Oncosec, Oncotelic, Shenzhen SiBiono GeneTech, Sillajen BiOthersapeutics, Tocagen, UniQure, Ziopharm Oncology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gene Therapy in Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Therapy in Oncology Market report?

Ans: The main players in the Gene Therapy in Oncology Market are Bristol-Myers Squibb, Cold Genesys, Advantagene, Amgen, AstraZeneca, Bio-Path Holdings, CRISPR Therapeutics, Editas Medicine, Geron Corp, Idera Pharmaceuticals, Intellia Therapeutics, Johnson & Johnson, Marsala Biotech, Merck, Mologen AG, Oncolytics Biotech, Oncosec, Oncotelic, Shenzhen SiBiono GeneTech, Sillajen BiOthersapeutics, Tocagen, UniQure, Ziopharm Oncology

What are the Application segmentation covered in the Gene Therapy in Oncology Market report?

Ans: The Applications covered in the Gene Therapy in Oncology Market report are Hospitals, Diagnostics Centers, Research Institutes

What are the Type segmentation covered in the Gene Therapy in Oncology Market report?

Ans: The Types covered in the Gene Therapy in Oncology Market report are Ex Vivo, In Vivo

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy in Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ex Vivo
1.2.3 In Vivo
1.3 Market by Application
1.3.1 Global Gene Therapy in Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy in Oncology Market Perspective (2020-2031)
2.2 Global Gene Therapy in Oncology Growth Trends by Region
2.2.1 Global Gene Therapy in Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Therapy in Oncology Historic Market Size by Region (2020-2025)
2.2.3 Gene Therapy in Oncology Forecasted Market Size by Region (2026-2031)
2.3 Gene Therapy in Oncology Market Dynamics
2.3.1 Gene Therapy in Oncology Industry Trends
2.3.2 Gene Therapy in Oncology Market Drivers
2.3.3 Gene Therapy in Oncology Market Challenges
2.3.4 Gene Therapy in Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy in Oncology Players by Revenue
3.1.1 Global Top Gene Therapy in Oncology Players by Revenue (2020-2025)
3.1.2 Global Gene Therapy in Oncology Revenue Market Share by Players (2020-2025)
3.2 Global Gene Therapy in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Therapy in Oncology Revenue
3.4 Global Gene Therapy in Oncology Market Concentration Ratio
3.4.1 Global Gene Therapy in Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy in Oncology Revenue in 2024
3.5 Global Key Players of Gene Therapy in Oncology Head office and Area Served
3.6 Global Key Players of Gene Therapy in Oncology, Product and Application
3.7 Global Key Players of Gene Therapy in Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy in Oncology Breakdown Data by Type
4.1 Global Gene Therapy in Oncology Historic Market Size by Type (2020-2025)
4.2 Global Gene Therapy in Oncology Forecasted Market Size by Type (2026-2031)
5 Gene Therapy in Oncology Breakdown Data by Application
5.1 Global Gene Therapy in Oncology Historic Market Size by Application (2020-2025)
5.2 Global Gene Therapy in Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Therapy in Oncology Market Size (2020-2031)
6.2 North America Gene Therapy in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Therapy in Oncology Market Size by Country (2020-2025)
6.4 North America Gene Therapy in Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy in Oncology Market Size (2020-2031)
7.2 Europe Gene Therapy in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Therapy in Oncology Market Size by Country (2020-2025)
7.4 Europe Gene Therapy in Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy in Oncology Market Size (2020-2031)
8.2 Asia-Pacific Gene Therapy in Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Therapy in Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Therapy in Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy in Oncology Market Size (2020-2031)
9.2 Latin America Gene Therapy in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Therapy in Oncology Market Size by Country (2020-2025)
9.4 Latin America Gene Therapy in Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy in Oncology Market Size (2020-2031)
10.2 Middle East & Africa Gene Therapy in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Therapy in Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Therapy in Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Introduction
11.1.4 Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2020-2025)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Cold Genesys
11.2.1 Cold Genesys Company Details
11.2.2 Cold Genesys Business Overview
11.2.3 Cold Genesys Gene Therapy in Oncology Introduction
11.2.4 Cold Genesys Revenue in Gene Therapy in Oncology Business (2020-2025)
11.2.5 Cold Genesys Recent Development
11.3 Advantagene
11.3.1 Advantagene Company Details
11.3.2 Advantagene Business Overview
11.3.3 Advantagene Gene Therapy in Oncology Introduction
11.3.4 Advantagene Revenue in Gene Therapy in Oncology Business (2020-2025)
11.3.5 Advantagene Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Gene Therapy in Oncology Introduction
11.4.4 Amgen Revenue in Gene Therapy in Oncology Business (2020-2025)
11.4.5 Amgen Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Gene Therapy in Oncology Introduction
11.5.4 AstraZeneca Revenue in Gene Therapy in Oncology Business (2020-2025)
11.5.5 AstraZeneca Recent Development
11.6 Bio-Path Holdings
11.6.1 Bio-Path Holdings Company Details
11.6.2 Bio-Path Holdings Business Overview
11.6.3 Bio-Path Holdings Gene Therapy in Oncology Introduction
11.6.4 Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2020-2025)
11.6.5 Bio-Path Holdings Recent Development
11.7 CRISPR Therapeutics
11.7.1 CRISPR Therapeutics Company Details
11.7.2 CRISPR Therapeutics Business Overview
11.7.3 CRISPR Therapeutics Gene Therapy in Oncology Introduction
11.7.4 CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2020-2025)
11.7.5 CRISPR Therapeutics Recent Development
11.8 Editas Medicine
11.8.1 Editas Medicine Company Details
11.8.2 Editas Medicine Business Overview
11.8.3 Editas Medicine Gene Therapy in Oncology Introduction
11.8.4 Editas Medicine Revenue in Gene Therapy in Oncology Business (2020-2025)
11.8.5 Editas Medicine Recent Development
11.9 Geron Corp
11.9.1 Geron Corp Company Details
11.9.2 Geron Corp Business Overview
11.9.3 Geron Corp Gene Therapy in Oncology Introduction
11.9.4 Geron Corp Revenue in Gene Therapy in Oncology Business (2020-2025)
11.9.5 Geron Corp Recent Development
11.10 Idera Pharmaceuticals
11.10.1 Idera Pharmaceuticals Company Details
11.10.2 Idera Pharmaceuticals Business Overview
11.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Introduction
11.10.4 Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2020-2025)
11.10.5 Idera Pharmaceuticals Recent Development
11.11 Intellia Therapeutics
11.11.1 Intellia Therapeutics Company Details
11.11.2 Intellia Therapeutics Business Overview
11.11.3 Intellia Therapeutics Gene Therapy in Oncology Introduction
11.11.4 Intellia Therapeutics Revenue in Gene Therapy in Oncology Business (2020-2025)
11.11.5 Intellia Therapeutics Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Gene Therapy in Oncology Introduction
11.12.4 Johnson & Johnson Revenue in Gene Therapy in Oncology Business (2020-2025)
11.12.5 Johnson & Johnson Recent Development
11.13 Marsala Biotech
11.13.1 Marsala Biotech Company Details
11.13.2 Marsala Biotech Business Overview
11.13.3 Marsala Biotech Gene Therapy in Oncology Introduction
11.13.4 Marsala Biotech Revenue in Gene Therapy in Oncology Business (2020-2025)
11.13.5 Marsala Biotech Recent Development
11.14 Merck
11.14.1 Merck Company Details
11.14.2 Merck Business Overview
11.14.3 Merck Gene Therapy in Oncology Introduction
11.14.4 Merck Revenue in Gene Therapy in Oncology Business (2020-2025)
11.14.5 Merck Recent Development
11.15 Mologen AG
11.15.1 Mologen AG Company Details
11.15.2 Mologen AG Business Overview
11.15.3 Mologen AG Gene Therapy in Oncology Introduction
11.15.4 Mologen AG Revenue in Gene Therapy in Oncology Business (2020-2025)
11.15.5 Mologen AG Recent Development
11.16 Oncolytics Biotech
11.16.1 Oncolytics Biotech Company Details
11.16.2 Oncolytics Biotech Business Overview
11.16.3 Oncolytics Biotech Gene Therapy in Oncology Introduction
11.16.4 Oncolytics Biotech Revenue in Gene Therapy in Oncology Business (2020-2025)
11.16.5 Oncolytics Biotech Recent Development
11.17 Oncosec
11.17.1 Oncosec Company Details
11.17.2 Oncosec Business Overview
11.17.3 Oncosec Gene Therapy in Oncology Introduction
11.17.4 Oncosec Revenue in Gene Therapy in Oncology Business (2020-2025)
11.17.5 Oncosec Recent Development
11.18 Oncotelic
11.18.1 Oncotelic Company Details
11.18.2 Oncotelic Business Overview
11.18.3 Oncotelic Gene Therapy in Oncology Introduction
11.18.4 Oncotelic Revenue in Gene Therapy in Oncology Business (2020-2025)
11.18.5 Oncotelic Recent Development
11.19 Shenzhen SiBiono GeneTech
11.19.1 Shenzhen SiBiono GeneTech Company Details
11.19.2 Shenzhen SiBiono GeneTech Business Overview
11.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Introduction
11.19.4 Shenzhen SiBiono GeneTech Revenue in Gene Therapy in Oncology Business (2020-2025)
11.19.5 Shenzhen SiBiono GeneTech Recent Development
11.20 Sillajen BiOthersapeutics
11.20.1 Sillajen BiOthersapeutics Company Details
11.20.2 Sillajen BiOthersapeutics Business Overview
11.20.3 Sillajen BiOthersapeutics Gene Therapy in Oncology Introduction
11.20.4 Sillajen BiOthersapeutics Revenue in Gene Therapy in Oncology Business (2020-2025)
11.20.5 Sillajen BiOthersapeutics Recent Development
11.21 Tocagen
11.21.1 Tocagen Company Details
11.21.2 Tocagen Business Overview
11.21.3 Tocagen Gene Therapy in Oncology Introduction
11.21.4 Tocagen Revenue in Gene Therapy in Oncology Business (2020-2025)
11.21.5 Tocagen Recent Development
11.22 UniQure
11.22.1 UniQure Company Details
11.22.2 UniQure Business Overview
11.22.3 UniQure Gene Therapy in Oncology Introduction
11.22.4 UniQure Revenue in Gene Therapy in Oncology Business (2020-2025)
11.22.5 UniQure Recent Development
11.23 Ziopharm Oncology
11.23.1 Ziopharm Oncology Company Details
11.23.2 Ziopharm Oncology Business Overview
11.23.3 Ziopharm Oncology Gene Therapy in Oncology Introduction
11.23.4 Ziopharm Oncology Revenue in Gene Therapy in Oncology Business (2020-2025)
11.23.5 Ziopharm Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bristol–Myers Squibb
Cold Genesys
Advantagene Inc
Amgen Inc
Astrazeneca plc
Bio-Path Holdings
CRISPR Therapeutics
Editas Medicine
Geron Corp
Idera Pharmaceuticals
Intellia Therapeutics
Johnson & Johnson
Marsala Biotech
Merck
Mologen AG
Oncolytics Biotech
Oncosec
Oncotelic
Shenzhen SiBiono GeneTech
Tocagen
Uniqure
ZIOPHARM Oncology
Sillajen BiOthersapeutics
Johnson & Johnson
List of Tables
 Table 1. Global Gene Therapy in Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Ex Vivo
 Table 3. Key Players of In Vivo
 Table 4. Global Gene Therapy in Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Gene Therapy in Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Gene Therapy in Oncology Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Gene Therapy in Oncology Market Share by Region (2020-2025)
 Table 8. Global Gene Therapy in Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Gene Therapy in Oncology Market Share by Region (2026-2031)
 Table 10. Gene Therapy in Oncology Market Trends
 Table 11. Gene Therapy in Oncology Market Drivers
 Table 12. Gene Therapy in Oncology Market Challenges
 Table 13. Gene Therapy in Oncology Market Restraints
 Table 14. Global Gene Therapy in Oncology Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Gene Therapy in Oncology Market Share by Players (2020-2025)
 Table 16. Global Top Gene Therapy in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in Oncology as of 2024)
 Table 17. Ranking of Global Top Gene Therapy in Oncology Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Gene Therapy in Oncology Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Gene Therapy in Oncology, Headquarters and Area Served
 Table 20. Global Key Players of Gene Therapy in Oncology, Product and Application
 Table 21. Global Key Players of Gene Therapy in Oncology, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Gene Therapy in Oncology Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Gene Therapy in Oncology Revenue Market Share by Type (2020-2025)
 Table 25. Global Gene Therapy in Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Gene Therapy in Oncology Revenue Market Share by Type (2026-2031)
 Table 27. Global Gene Therapy in Oncology Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Gene Therapy in Oncology Revenue Market Share by Application (2020-2025)
 Table 29. Global Gene Therapy in Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Gene Therapy in Oncology Revenue Market Share by Application (2026-2031)
 Table 31. North America Gene Therapy in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Gene Therapy in Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Gene Therapy in Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Gene Therapy in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Gene Therapy in Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Gene Therapy in Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Gene Therapy in Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Gene Therapy in Oncology Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Gene Therapy in Oncology Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gene Therapy in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Gene Therapy in Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Gene Therapy in Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Gene Therapy in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Gene Therapy in Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Gene Therapy in Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Bristol-Myers Squibb Company Details
 Table 47. Bristol-Myers Squibb Business Overview
 Table 48. Bristol-Myers Squibb Gene Therapy in Oncology Product
 Table 49. Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 50. Bristol-Myers Squibb Recent Development
 Table 51. Cold Genesys Company Details
 Table 52. Cold Genesys Business Overview
 Table 53. Cold Genesys Gene Therapy in Oncology Product
 Table 54. Cold Genesys Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 55. Cold Genesys Recent Development
 Table 56. Advantagene Company Details
 Table 57. Advantagene Business Overview
 Table 58. Advantagene Gene Therapy in Oncology Product
 Table 59. Advantagene Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 60. Advantagene Recent Development
 Table 61. Amgen Company Details
 Table 62. Amgen Business Overview
 Table 63. Amgen Gene Therapy in Oncology Product
 Table 64. Amgen Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 65. Amgen Recent Development
 Table 66. AstraZeneca Company Details
 Table 67. AstraZeneca Business Overview
 Table 68. AstraZeneca Gene Therapy in Oncology Product
 Table 69. AstraZeneca Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 70. AstraZeneca Recent Development
 Table 71. Bio-Path Holdings Company Details
 Table 72. Bio-Path Holdings Business Overview
 Table 73. Bio-Path Holdings Gene Therapy in Oncology Product
 Table 74. Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 75. Bio-Path Holdings Recent Development
 Table 76. CRISPR Therapeutics Company Details
 Table 77. CRISPR Therapeutics Business Overview
 Table 78. CRISPR Therapeutics Gene Therapy in Oncology Product
 Table 79. CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 80. CRISPR Therapeutics Recent Development
 Table 81. Editas Medicine Company Details
 Table 82. Editas Medicine Business Overview
 Table 83. Editas Medicine Gene Therapy in Oncology Product
 Table 84. Editas Medicine Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 85. Editas Medicine Recent Development
 Table 86. Geron Corp Company Details
 Table 87. Geron Corp Business Overview
 Table 88. Geron Corp Gene Therapy in Oncology Product
 Table 89. Geron Corp Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 90. Geron Corp Recent Development
 Table 91. Idera Pharmaceuticals Company Details
 Table 92. Idera Pharmaceuticals Business Overview
 Table 93. Idera Pharmaceuticals Gene Therapy in Oncology Product
 Table 94. Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 95. Idera Pharmaceuticals Recent Development
 Table 96. Intellia Therapeutics Company Details
 Table 97. Intellia Therapeutics Business Overview
 Table 98. Intellia Therapeutics Gene Therapy in Oncology Product
 Table 99. Intellia Therapeutics Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 100. Intellia Therapeutics Recent Development
 Table 101. Johnson & Johnson Company Details
 Table 102. Johnson & Johnson Business Overview
 Table 103. Johnson & Johnson Gene Therapy in Oncology Product
 Table 104. Johnson & Johnson Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 105. Johnson & Johnson Recent Development
 Table 106. Marsala Biotech Company Details
 Table 107. Marsala Biotech Business Overview
 Table 108. Marsala Biotech Gene Therapy in Oncology Product
 Table 109. Marsala Biotech Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 110. Marsala Biotech Recent Development
 Table 111. Merck Company Details
 Table 112. Merck Business Overview
 Table 113. Merck Gene Therapy in Oncology Product
 Table 114. Merck Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 115. Merck Recent Development
 Table 116. Mologen AG Company Details
 Table 117. Mologen AG Business Overview
 Table 118. Mologen AG Gene Therapy in Oncology Product
 Table 119. Mologen AG Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 120. Mologen AG Recent Development
 Table 121. Oncolytics Biotech Company Details
 Table 122. Oncolytics Biotech Business Overview
 Table 123. Oncolytics Biotech Gene Therapy in Oncology Product
 Table 124. Oncolytics Biotech Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 125. Oncolytics Biotech Recent Development
 Table 126. Oncosec Company Details
 Table 127. Oncosec Business Overview
 Table 128. Oncosec Gene Therapy in Oncology Product
 Table 129. Oncosec Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 130. Oncosec Recent Development
 Table 131. Oncotelic Company Details
 Table 132. Oncotelic Business Overview
 Table 133. Oncotelic Gene Therapy in Oncology Product
 Table 134. Oncotelic Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 135. Oncotelic Recent Development
 Table 136. Shenzhen SiBiono GeneTech Company Details
 Table 137. Shenzhen SiBiono GeneTech Business Overview
 Table 138. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product
 Table 139. Shenzhen SiBiono GeneTech Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 140. Shenzhen SiBiono GeneTech Recent Development
 Table 141. Sillajen BiOthersapeutics Company Details
 Table 142. Sillajen BiOthersapeutics Business Overview
 Table 143. Sillajen BiOthersapeutics Gene Therapy in Oncology Product
 Table 144. Sillajen BiOthersapeutics Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 145. Sillajen BiOthersapeutics Recent Development
 Table 146. Tocagen Company Details
 Table 147. Tocagen Business Overview
 Table 148. Tocagen Gene Therapy in Oncology Product
 Table 149. Tocagen Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 150. Tocagen Recent Development
 Table 151. UniQure Company Details
 Table 152. UniQure Business Overview
 Table 153. UniQure Gene Therapy in Oncology Product
 Table 154. UniQure Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 155. UniQure Recent Development
 Table 156. Ziopharm Oncology Company Details
 Table 157. Ziopharm Oncology Business Overview
 Table 158. Ziopharm Oncology Gene Therapy in Oncology Product
 Table 159. Ziopharm Oncology Revenue in Gene Therapy in Oncology Business (2020-2025) & (US$ Million)
 Table 160. Ziopharm Oncology Recent Development
 Table 161. Research Programs/Design for This Report
 Table 162. Key Data Information from Secondary Sources
 Table 163. Key Data Information from Primary Sources
 Table 164. Authors List of This Report


List of Figures
 Figure 1. Gene Therapy in Oncology Picture
 Figure 2. Global Gene Therapy in Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gene Therapy in Oncology Market Share by Type: 2024 VS 2031
 Figure 4. Ex Vivo Features
 Figure 5. In Vivo Features
 Figure 6. Global Gene Therapy in Oncology Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Gene Therapy in Oncology Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Diagnostics Centers Case Studies
 Figure 10. Research Institutes Case Studies
 Figure 11. Gene Therapy in Oncology Report Years Considered
 Figure 12. Global Gene Therapy in Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Gene Therapy in Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Gene Therapy in Oncology Market Share by Region: 2024 VS 2031
 Figure 15. Global Gene Therapy in Oncology Market Share by Players in 2024
 Figure 16. Global Top Gene Therapy in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in Oncology as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy in Oncology Revenue in 2024
 Figure 18. North America Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Gene Therapy in Oncology Market Share by Country (2020-2031)
 Figure 20. United States Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Gene Therapy in Oncology Market Share by Country (2020-2031)
 Figure 24. Germany Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Gene Therapy in Oncology Market Share by Region (2020-2031)
 Figure 32. China Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Gene Therapy in Oncology Market Share by Country (2020-2031)
 Figure 40. Mexico Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Gene Therapy in Oncology Market Share by Country (2020-2031)
 Figure 44. Turkey Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Gene Therapy in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 48. Cold Genesys Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 49. Advantagene Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 50. Amgen Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 51. AstraZeneca Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 52. Bio-Path Holdings Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 53. CRISPR Therapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 54. Editas Medicine Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 55. Geron Corp Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 56. Idera Pharmaceuticals Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 57. Intellia Therapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 58. Johnson & Johnson Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 59. Marsala Biotech Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 60. Merck Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 61. Mologen AG Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 62. Oncolytics Biotech Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 63. Oncosec Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 64. Oncotelic Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 65. Shenzhen SiBiono GeneTech Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 66. Sillajen BiOthersapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 67. Tocagen Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 68. UniQure Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 69. Ziopharm Oncology Revenue Growth Rate in Gene Therapy in Oncology Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Gene Therapy For Cancer Market Research Report 2024
Global In Vitro Gene Therapy Market Research Report 2025
Global Gene Therapies for Cancer Treatment Market Research Report 2024
Global Non viral Vectors Gene Therapy Market Research Report 2025
Global Gene Therapies for Tumor Treatment Market Insights Forecast to 2030
Global Cell and Gene Therapy Solutions Market Research Report 2025
Global Gene Editing Therapy Market Research Report 2024
Gene Therapy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Therapy Drug Delivery Tube Market Research Report 2024
Global Gene Detection for Individualized Cancer Therapy Market Research Report 2024
Global Ocular Gene Therapy Market Research Report 2024
Global Viral Vector Based Gene Therapy Market Research Report 2025
Gene Therapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy on Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nucleic Acid Based Gene Therapeutics Market Research Report 2024
Global Gene Therapy for CNS Disorders Market Research Report 2024
Global Optogenetic Gene Therapy Market Research Report 2024
Gene Therapy For Heart Failure Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemophilia Gene Therapy Market Research Report 2025

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions